Week In Review: Fosun Pharma Acquires Majority Stake In China Vaccine Company For $682 Million
October 30, 2021 at 14:47 PM EDT
Fosun Pharma announced a $628 million deal to acquire a 73% stake in Chengdu Antejin Biotech, a vaccine company. Fosun paid $174 million to nine Antejin shareholders and it contributed its own subsidiary, Dalian Aleph Biomedical, for the remainder.
